The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EA2183: A phase III study of consolidative radiotherapy in patients with oligometastatic HER2-negative esophageal and gastric adenocarcinoma.
 
Nataliya Volodymyrivna Uboha
Stock and Other Ownership Interests - Exact Sciences (I); Natera (I)
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Gerson Lehrman Group; Guidepoint Global; Helsinn Therapeutics; Incyte; ipsen; LEK; Lilly; Lilly; M3; Pfizer; QED Therapeutics; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - EMD Serono (Inst); ipsen (Inst); Lilly (Inst); Taiho Pharmaceutical (Inst)
 
Noah Graham
No Relationships to Disclose
 
Lakshmi Rajdev
Consulting or Advisory Role - AstraZeneca; Incyte
 
Michael K. Gibson
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Daiichi Sankyo; Flagship Biosciences; Merck; Soligenix; Teckro
Research Funding - PapiVax Biotech, Inc. (Inst)
Other Relationship - UpToDate
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Advanced Accelerator Applications; Ipsen
Consulting or Advisory Role - Ipsen; Merck; Taiho Pharmaceutical
Research Funding - Aduro Biotech (Inst); Forty seven (Inst); Genentech/Roche (Inst); Merck (Inst); Newlink Genetics (Inst)
Travel, Accommodations, Expenses - Merck; Roche/Genentech
Other Relationship - AstraZeneca; CytomX Therapeutics; Hutchison MediPharma; Silenseed; Taiho Pharmaceutical; Terumo Clinical Supply
 
Steven H. Lin
Employment - MD Anderson Cancer Center
Stock and Other Ownership Interests - Scenexo
Honoraria - AstraZeneca/MedImmune; BeyondSpring Pharmaceuticals
Consulting or Advisory Role - Scenexo
Speakers' Bureau - AstraZeneca
Research Funding - BeyondSpring Pharmaceuticals; Nektar; STCube Pharmaceuticals Inc.
Travel, Accommodations, Expenses - Elekta; STCube Pharmaceuticals Inc.
 
Bapsi Chakravarthy
No Relationships to Disclose
 
Peter J. O'Dwyer
Consulting or Advisory Role - Genentech
Research Funding - Amgen (Inst); Array BioPharma (Inst); BBI Healthcare (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); GlaxoSmithKline (Inst); H3 Biomedicine (Inst); Lilly/ImClone (Inst); Minneamrita Therapeutics (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); syndax (Inst); Syndax (Inst); Syndax (Inst); Syndax (Inst); Syndax (Inst); Taiho Pharmaceutical (Inst)
Expert Testimony - Dai-ichi Sankyo; Lilly